Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination

Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

NCT00135005 ·Status: COMPLETED ·Phase: PHASE1

Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma

NCT00401024 ·Status: COMPLETED ·Phase: PHASE1

Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor

NCT00103168 ·Status: COMPLETED ·Phase: PHASE3

Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation

NCT00278876 ·Status: COMPLETED ·Phase: PHASE2

Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects

NCT00529763 ·Status: COMPLETED ·Phase: PHASE2

Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors

NCT04933669 ·Status: RECRUITING ·Phase: PHASE2

Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)

NCT00867113 ·Status: COMPLETED ·Phase: PHASE2

A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract

NCT04195373 ·Status: WITHDRAWN ·Phase: PHASE1

Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)

NCT00089960 ·Status: COMPLETED ·Phase: PHASE2

Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT

NCT01151852 ·Status: COMPLETED ·Phase: PHASE3

Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor

NCT01267695 ·Status: COMPLETED ·Phase: PHASE2

Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)

NCT00171977 ·Status: COMPLETED ·Phase: PHASE4

Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib

NCT00441155 ·Status: COMPLETED ·Phase: PHASE1

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

NCT00551252 ·Status: UNKNOWN ·Phase: PHASE2

A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment

NCT03092128 ·Status: UNKNOWN

Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct

NCT01153750 ·Status: COMPLETED ·Phase: PHASE2

Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma

NCT00881049 ·Status: COMPLETED ·Phase: PHASE2

Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib

NCT02607332 ·Status: COMPLETED ·Phase: PHASE2

Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions

NCT02103322 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors

NCT00611689 ·Status: COMPLETED ·Phase: PHASE1

A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors

NCT00940563 ·Status: COMPLETED ·Phase: PHASE2

Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST

NCT00500188 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib

NCT01478373 ·Status: COMPLETED ·Phase: PHASE2

Glivec Phase II Pediatric Study

NCT00180830 ·Status: TERMINATED ·Phase: PHASE2

Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients

NCT01031628 ·Status: TERMINATED ·Phase: PHASE3